DrugPatentWatch Database Preview

Drugs in Development Information for Givinostat

US Patents	7
International Patents	58
US Patent Applications	14
WIPO Patent Applications	10
Japanese Patent Applications	0
Clinical Trial Progress	Phase 2 (2016-10-01)
Vendors	15

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
Givinostat	➤ Sign Up	Monohydrate hydrochloride of the 4-hydroxycarbamoyl-phenyl)-carbamic acid (6-diethylaminomethyl-naphtalen-2-yl) ester	Italfarmaco SpA (Milano, IT)	➤ Sign Up
Givinostat	➤ Sign Up	Method for treating Philadelphia-negative myeloproliferative syndromes	Italfarmaco SpA (Milan, IT)	➤ Sign Up
Givinostat	➤ Sign Up	Polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphthalenyl) ester	Chemi SPA (Cinisello Balsamo, IT)	➤ Sign Up
Givinostat	➤ Sign Up	Thioxanthone-based autophagy inhibitor therapies to treat cancer	Spectrum Pharmaceuticals, Inc. (Irvine, CA)	➤ Sign Up
Givinostat	➤ Sign Up	Derivatives of N-hydroxybenzamide for treating HIV infections	Italfarmaco S.p.A. (Milan, IT)	➤ Sign Up
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Drugname	Country	Document Number	Estimated Expiration	Related US Patent
Givinostat	European Patent Office	1583737	2023-01-17	➤ Sign Up
Givinostat	Spain	2372280	2023-01-17	➤ Sign Up
Givinostat	Italy	MI20030063	2023-01-17	➤ Sign Up
Givinostat	Japan	2006515028	2023-01-17	➤ Sign Up
Givinostat	Japan	4425906	2023-01-17	➤ Sign Up
Drugname	Country	Document Number	Estimated Expiration	Related US Patent